Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shubitong Granules
- Development stage
- Unknown
- Lead developer
- Anhui Pioneer Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shubitong Granules (also known as Schubert or Shumitong Granules) is an approved traditional Chinese medicine (TCM) developed and manufactured by Anhui Pioneer Pharmaceutical. Formulated as oral granules, it is composed of Clematis armandii stem (Chuanmutong), Uncaria rhynchophylla (Gouteng), Chrysanthemum indicum (Yejuhua), and Lysimachia christinae (Jinqiancao). Shubitong Granules is indicated for clearing heat, detoxifying, inducing diuresis to treat stranguria, and softening hard masses to resolve stagnation. It is primarily used to treat patients suffering from obstructive urination caused by the accumulation of damp-heat, reduced urine volume, hot redness or discomfort during urination, and prostate hypertrophy (benign prostatic hyperplasia).
- Brand names
- Schubert
- Other names
- ShubitongShumitongShumitong Granules舒泌通颗粒
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)EGFR (Epidermal growth factor receptor)GAPDH (Glyceraldehyde-3-phosphate dehydrogenase)IL-6 (Interleukin 6)TP53 (Cellular Tumor Antigen p53 R175H)
Beyond the preview
Go deeper on Shubitong Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shubitong Granules.